GREENLAND MINES LTD Increase (Decrease) in Other Accounts Payable
GREENLAND MINES LTD (GRML) reported Increase (Decrease) in Other Accounts Payable of -$19.08 thousand for the 12-month period ending 2025-12-31, per its 10-K/A filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccountsPayable · last filed 2026-08-14
- GREENLAND MINES LTD increase (decrease) in other accounts payable for the quarter ending 2025-12-31 was $9.70K.
- GREENLAND MINES LTD increase (decrease) in other accounts payable for the quarter ending 2025-09-30 was $22.27K, a 83.76% decline year-over-year.
- GREENLAND MINES LTD increase (decrease) in other accounts payable for the quarter ending 2025-06-30 was -$53.92K.
- GREENLAND MINES LTD increase (decrease) in other accounts payable for the quarter ending 2025-03-31 was $2.86K, a 99.07% decline year-over-year.
- GREENLAND MINES LTD increase (decrease) in other accounts payable for fiscal 2025 was -$19.08K.
- GREENLAND MINES LTD increase (decrease) in other accounts payable for fiscal 2024 was -$187.57K, a 280.36% decline from fiscal 2023.
- GREENLAND MINES LTD increase (decrease) in other accounts payable for fiscal 2023 was $104.00K.
| Period end | Increase (Decrease) in Other Accounts Payable 3 month | Increase (Decrease) in Other Accounts Payable 6 month | Increase (Decrease) in Other Accounts Payable 9 month | Increase (Decrease) in Other Accounts Payable 12 month |
|---|---|---|---|---|
| 2025-12-31 | $9.70K derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-08-14 | $31.98K derived: sum of 2 quarters · filed 2026-08-14 | -$21.94K derived: sum of 3 quarters · filed 2026-08-14 | -$19.08K 10-K/A · filed 2026-08-14 |
| 2025-09-30 | $22.27K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$31.64K derived: sum of 2 quarters · filed 2025-11-13 | -$28.78K 10-Q · filed 2025-11-13 | -$236.22K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$53.92K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-18 | -$51.05K 10-Q · filed 2025-08-18 | -$258.50K derived: sum of 3 quarters · filed 2026-08-14 | -$121.36K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $2.86K 10-Q · filed 2025-05-15 | -$204.58K derived: sum of 2 quarters · filed 2026-08-14 | -$67.44K derived: sum of 3 quarters · filed 2026-08-14 | -$493.69K derived: sum of 4 quarters · filed 2026-08-14 |
| 2024-12-31 | -$207.44K derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-08-14 | -$70.30K derived: sum of 2 quarters · filed 2026-08-14 | -$496.55K derived: sum of 3 quarters · filed 2026-08-14 | -$187.57K 10-K/A · filed 2026-08-14 |
| 2024-09-30 | $137.14K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$289.11K derived: sum of 2 quarters · filed 2025-11-13 | $19.87K 10-Q · filed 2025-11-13 | -$45.10K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | -$426.25K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-18 | -$117.27K 10-Q · filed 2025-08-18 | -$182.24K derived: sum of 3 quarters · filed 2025-08-18 | |
| 2024-03-31 | $308.98K 10-Q · filed 2025-05-15 | $244.01K derived: sum of 2 quarters · filed 2025-05-15 | ||
| 2023-12-31 | -$64.97K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $104.00K 10-K · filed 2025-03-31 | ||
| 2023-09-30 | $168.97K 10-Q · filed 2024-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |